MedTrace Logo

The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus

NCT03338205 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2024-02-06

No results posted yet for this study

Summary

The purpose of this investigation is to perform a pilot study assessing the safety and utility of intravenous ketamine as an adjuvant therapy in the emergency department setting for pediatric patients in acute status asthmaticus who have failed standard emergency therapy.

Conditions

  • Status Asthmaticus

Interventions

DRUG

Ketamine

1 mg/kg ketamine bolus IV

Sponsors & Collaborators

  • Augusta University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-31
Primary Completion
2021-12-31
Completion
2022-01-31
FDA Drug
Yes

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03338205 on ClinicalTrials.gov